Hikma Pharmaceuticals PLC (HIK)

Hikma (HIK) creates and sells generic pharmaceutical solutions and products in the USA, North Africa, Europe, and the Middle East. In all, the company has operations in more than 50 countries and divides its work into three business units: Branded, Injectables, and Generics. The most popular products from the Branded division are: Amoclan, Omnisef, Blopress, Suprax and other. Hikma share price information: Hikma shares are traded on the London Stock Exchange (LSE). The company constitutes the FTSE 250 index. Follow Capital.com to stay tuned to the Hikma Pharmaceutical share price.